Amisulpride augmentation after the failure of citalopram for depression: a case report

被引：5

作者：

Carvalho, A. F. ^{[1
]}

Nunes-Neto, P. R. ^{[1
]}

Cavalcante, J. L. ^{[1
]}

Lima, M. C. Oliveira ^{[1
]}

机构：

[1] Univ Fed Ceara, Psychiat Outpatient Clin, Dept Clin Med, Fortaleza, Ceara, Brazil

来源：

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2007年 / 32卷 / 01期

关键词：

amisulpride; citalopram; combination; depression; drug therapy; NONRESPONDERS;

D O I：

10.1111/j.1365-2710.2007.00787.x

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

This case report describes a 35-year-old woman with a first depressive episode. She was treated with the serotonergic antidepressant citalopram for 12 weeks without therapeutic response. Low-dose amisulpride augmentation resulted in a significant clinical improvement. We hypothesize that the dopaminergic properties of amisulpride might augment the effects of serotonergic antidepressants in refractory patients.

引用

页码：97 / 99

页数：3

共 14 条

[1]

de la Gándara J, 2005, ACTA PSYCHIAT SCAND, V112, P11

[2]

A prospective trial of bupropion SR augmentation of partial and non-responders to Serotonergic antidepressants [J].

DeBattista, C ;

Solvason, HB ;

Poirier, J ;

Kendrick, E ;

Schatzberg, AF .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) :27-30

[3]

Australian and New Zealand clinical practice guidelines for the treatment of depression [J].

Ellis, PM ;

Hickie, I ;

Smith, DAR ;

Bushnell, J ;

Hirini, P ;

Stevens, S ;

Smith, DAR .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2004, 38 (06) :389-407

[4]

Definition and epidemiology of treatment-resistant depression [J].

Fava, M ;

Davidson, KG .

PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 19 (02) :179-&

[5]

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine [J].

Fava, M ;

Alpert, J ;

Nierenberg, A ;

Lagomasino, I ;

Sonawalla, S ;

Tedlow, J ;

Worthington, J ;

Baer, L ;

Rosenbaum, JF .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (04) :379-387

[6]

A RATING SCALE FOR DEPRESSION [J].

HAMILTON, M .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62

[7]

Amisulpride versus imipramine and placebo in dysthymia and major depression [J].

Lecrubier, Y ;

Boyer, P ;

Turjanski, S ;

Rein, W .

JOURNAL OF AFFECTIVE DISORDERS, 1997, 43 (02) :95-103

[8]

Amisulpride, an unusual "atypical" antipsychotic: A meta-analysis of randomized controlled trials [J].

Leucht, S ;

Pitschel-Walz, G ;

Engel, RR ;

Kissling, W .

AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (02) :180-190

[9]

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians [J].

Mischoulon, D ;

Nierenberg, AA ;

Kizilbash, L ;

Rosenbaum, JF ;

Fava, M .

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2000, 45 (05) :476-481

[10]

Montgomery SA, 2002, INT CLIN PSYCHOPHARM, V17, pS9

← 1 2 →